2-178565094-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001267550.2(TTN):c.81038G>A(p.Arg27013Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000452 in 1,613,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.81038G>A | p.Arg27013Gln | missense_variant | Exon 326 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.81038G>A | p.Arg27013Gln | missense_variant | Exon 326 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152074Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000604 AC: 15AN: 248432Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134758
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461372Hom.: 0 Cov.: 37 AF XY: 0.0000399 AC XY: 29AN XY: 726982
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152074Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74284
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
- -
- -
Cardiovascular phenotype Uncertain:1
The p.R17948Q variant (also known as c.53843G>A), located in coding exon 153 of the TTN gene, results from a G to A substitution at nucleotide position 53843. The arginine at codon 17948 is replaced by glutamine, an amino acid with highly similar properties. This variant (referred to as p.R27013Q) co-occurred with a TTN frameshift variant in an individual from a dilated cardiomyopathy cohort (Minoche AE et al. Genet. Med., 2019 03;21:650-662). This variant (referred to as p.R24445Q) has also been reported as a secondary cardiac variant in an exome cohort (Ng D et al. Circ Cardiovasc Genet, 2013 Aug;6:337-46). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at